Clinical Overview

Semax is a synthetic heptapeptide derivative of the ACTH(4–10) fragment (sequence MEHFPGP) investigated for neurotrophic, neuromodulatory, and neuroprotective properties. In research models, Semax is utilized to explore synaptic plasticity, cognitive-process modulation, stress-resilience pathways, and cerebrovascular–neural coupling, with attention to learning/memory readouts and cortical network dynamics.

Mechanism of Action

Neurotrophin Signaling: Literature examines Semax-associated upregulation of neurotrophin pathways (e.g., BDNF-linked gene programs) with downstream MAPK/ERK and PI3K/Akt activity that supports synaptic protein expression and plasticity.
Neurotransmission: Reports evaluate modulation of monoaminergic tone (dopaminergic/serotonergic), glutamatergic balance (AMPA/NMDA), and cortical excitability parameters in translational paradigms.
Stress/Inflammation: Investigations probe antioxidant and anti-inflammatory responses, including redox homeostasis markers and stress-responsive transcription that may influence neuronal survival under challenge.

Research Applications

Learning and memory assays • Synaptic plasticity and LTP readouts • Cortical network oscillations and attention metrics • Neuroinflammation and oxidative-stress models • Cerebrovascular–neural coupling and recovery paradigms following experimental insult.

Purity & Quality Assurance

Revitalized Health peptides are produced under cGMP-aligned conditions with pharmaceutical-grade inputs. Each Semax lot is confirmed at ≥99% purity by HPLC with structure/identity verified via LC-MS/MS. Lots undergo appearance and solubility checks, plus microbial/endotoxin screening to research-grade specifications. Batch-level Certificates of Analysis document analytical methods, parameters, and results.

Storage & Stability

Store lyophilized vials at 2–8 °C, protected from light and moisture. Following reconstitution with bacteriostatic water, maintain at 2–8 °C and use within 20 days. Avoid repeated freeze–thaw cycles to preserve peptide integrity and receptor/target engagement fidelity.

Research Disclaimer

For laboratory research use only. Not intended for human consumption, therapeutic, or diagnostic application. Supplied exclusively to qualified professionals conducting controlled scientific investigations.

Formulated for research applications. Purity, identity, and lot analytics available per batch. Not medical advice.

Mechanism Strength
86/100
ACTH(4-10) analog • BDNF/TrkB
Neurocognitive Impact
84/100
Attention • executive support
Evidence Level
76/100
Preclinical + regional human data
Safety & Tolerability
92/100
Common: mild nasal/ISR; low sedation
PK / PD
Plasma t½ (IN)
Onset (Cognition)
Neurotrophic Signaling
Monoaminergic Modulation
Mechanism & Testing

Identity: Semax (Met-Glu-His-Phe-Pro-Gly-Pro), ACTH(4-10) analog.
Mode: Upregulates neurotrophic programs (BDNF/TrkB axis), modulates catecholaminergic turnover, and induces anti-oxidative/anti-inflammatory transcripts in models; associated with attention/executive performance paradigms in regional studies.
Analytics: HPLC/LC-MS identity & purity; stability. PD: cognitive batteries (CPT/Trail Making), EEG spectral metrics, HRV stress markers; cytokine/BDNF panels. Monitoring: local nasal tolerability, BP/HR as applicable.

Educational, research-style site content. Not medical advice.